Songtao Xue
Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation
Xue, Songtao; Li, Zhiwei; Ze, Xiaotong; Wu, Xiuyuan; He, Chen; Shuai, Wen; Marlow, Maria; Chen, Jian; Scurr, David; Zhu, Zheying; Xu, Jinyi; Xu, Shengtao
Authors
Zhiwei Li
Xiaotong Ze
Xiuyuan Wu
Chen He
Wen Shuai
MARIA MARLOW Maria.Marlow@nottingham.ac.uk
Associate Professor
JIAN CHEN JIAN.CHEN@NOTTINGHAM.AC.UK
Associate Professor
DAVID SCURR DAVID.SCURR@NOTTINGHAM.AC.UK
Principal Research Fellow
ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
Associate Professor in International Pharmacy and Traditional Medicines
Jinyi Xu
Shengtao Xu
Abstract
Excessive melanin deposition may lead to a series of skin disorders. The production of melanin is carried out by melanocytes, in which the enzyme tyrosinase performs a key role. In this work, we identified a series of novel tyrosinase inhibitor hybrids with a dihydrochalcone skeleton and resorcinol structure, which can inhibit tyrosinase activity and reduce the melanin content in the skin. Compound 11c possessed the most potent activity against tyrosinase, showing IC50 values at nanomolar concentration ranges, along with significant antioxidant activity and low cytotoxicity. Furthermore, in vitro permeation tests, supported by HPLC analysis and 3D OrbiSIMS imaging visualization, revealed the excellent permeation of 11c. More importantly, compound 11c reduced the melanin content on UV-induced skin pigmentation in a guinea pig model in vivo. These results suggest that compound 11c may serve as a promising potent tyrosinase inhibitor for the development of a potential therapy to treat skin hyperpigmentation.
Citation
Xue, S., Li, Z., Ze, X., Wu, X., He, C., Shuai, W., …Xu, S. (2023). Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation. Journal of Medicinal Chemistry, 66(7), 5099–5117. https://doi.org/10.1021/acs.jmedchem.3c00012
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 9, 2023 |
Online Publication Date | Mar 20, 2023 |
Publication Date | Mar 20, 2023 |
Deposit Date | Mar 21, 2023 |
Publicly Available Date | Mar 21, 2024 |
Journal | Journal of Medicinal Chemistry |
Print ISSN | 0022-2623 |
Electronic ISSN | 1520-4804 |
Publisher | American Chemical Society |
Peer Reviewed | Peer Reviewed |
Volume | 66 |
Issue | 7 |
Pages | 5099–5117 |
DOI | https://doi.org/10.1021/acs.jmedchem.3c00012 |
Keywords | Anatomy, Inhibition, Inhibitors, Ions, Peptides and proteins |
Public URL | https://nottingham-repository.worktribe.com/output/18808553 |
Publisher URL | https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00012 |
Additional Information | This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Journal of Medicinal Chemistry after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00012. |
Files
JMC 2023 - Skin
(2.4 Mb)
PDF
You might also like
Surface directed modulation of supramolecular gel properties
(2016)
Journal Article
Gelation properties of self-assembling N-acyl modified cytidine derivatives
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search